Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-25-107323
Filing Date
2025-08-12
Accepted
2025-08-12 16:11:48
Documents
15
Effectiveness Date
2025-08-12

Document Format Files

Seq Description Document Type Size
1 S-8 cue-20250812.htm S-8 143026
2 WH CONSENT cue-ex5_1.htm EX-5.1 23699
3 RSM CONSENT cue-ex23_2.htm EX-23.2 5311
4 EX-FILING FEES cue_exfilingfees.htm   iXBRL EX-FILING FEES 60073
5 GRAPHIC img152828397_0.jpg GRAPHIC 9385
  Complete submission text file 0000950170-25-107323.txt   370204

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT cue_exfilingfees_htm.xml XML 6789
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

EIN.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-289528 | Film No.: 251206816
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)